Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised antibody fragment (Ep-CAM)-truncated Pseudomonas exotoxin A fusion protein

EU orphan designation number: EU/3/05/290   
Active ingredient: Humanised antibody fragment (Ep-CAM)-truncated Pseudomonas exotoxin A fusion protein
Indication: Treatment of Ep-CAM-positive squamous cell carcinoma of the head and neck
Sponsor: Viventia Biotech (EU) Limited
Simmons & Simmons, City Point, One Ropemaker Street, London EC2Y 9SS, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/07/2005 Centralised Orphan - Designation EMEA/OD/099/04 (2005)1911 of 20/06/2005
18/11/2005 Centralised Orphan - Transfer of orphan designation EMEA/OD/099/04/T/01 (2005)4508 of 15/11/2005
24/01/2006 Other procedure